Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 10, 2012

View Archived Issues

Genentech presents phase II results for rontalizumab in patients with SLE

REP-9AC in combination with immunostimulatory agents proves effective in HBV-infected patients

Results of first-in-human study of NNC-0114-0005 reported

Preliminary results of a first-in-human study reveal good safety profile for DENV-1 PIV

Pivotal trial of Trimel's testosterone replacement therapy meets efficacy endpoints

Cytomedix signs agreement with NIH for phase II study of Bright Cells

Lipocine cleared to conduct phase III study of oral testosterone replacement product

Astex Pharmaceuticals presents promising preclinical results for AT-26893

Promising results seen in phase I study of immunoliposomes

RP-3133 significantly inhibits mast cell degranulation in vitro and in vivo

Dendrimer-enhanced docetaxel demonstrates superiority to Taxotere in animal trials

Veliparib shows antitumor activity in multiple myeloma

Novel guanylate cyclase activators developed at Bayer

Riesbeck Healthcare Sweden presents new candidate vaccines

U.S. scientists divulge novel c-Kit-targeting antibodies

AEM-28 given orphan drug status by FDA

New filovirus fusion proteins prepared

Bayer HealthCare submits MAA for Eylea

Bio-Path to expand development of BP-100-1.01

Merz Pharma patents novel mGlu5 receptor antagonists

New triacylglycerol lipase inhibitors designed by Roche

The EMA validates PTC Therapeutics' MAA for ataluren

FDA grants QIDP designation to two Cubist Pharmaceuticals antibiotic candidates

Pherin Pharmaceuticals reports phase II data for PH-94B

Janssen Biotech and Janssen Biologics seek additional approvals for Stelara

Sanofi Pasteur launches single-dose Japanese encephalitis vaccine in Australia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...